Quantcast

Latest Schering-Plough Stories

2014-08-26 12:30:05

New technologies on display include antibiotic-free drugs for livestock, stem cell products for bone healing and mobile devices to monitor pet fitness KANSAS CITY, Mo., Aug. 26, 2014 /PRNewswire-USNewswire/ -- The Kansas City Animal Health Corridor is hosting the world's only full-day investment forum for early and mid-stage animal health companies today at the KC Animal Health Investment Forum. Presenting companies, which hail from seven U.S. states and Canada, are seeking $500,000 to $20...

2014-08-14 08:29:19

SAN DIEGO, Aug. 14, 2014 /PRNewswire/ -- Formex, LLC ("Formex"), a leader in pharmaceutical development and manufacturing, announced that Mr. John McCarty has joined Formex as Scientific Advisor and Science Advisory Board Member. Mr. McCarty has over 30 years of experience in drug product development within the pharmaceutical and biotechnology industries. Mr. McCarty has broad expertise in the development of all major dosage forms and is an inventor on over 17 U.S. and foreign...

2014-07-30 08:32:55

- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor - PARIS and TARRYTOWN, N.Y., July 30, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to...

2014-07-23 12:30:34

CLEVELAND, July 23, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, a clinical-stage biotechnology company developing a first-in-class regenerative gene therapy for treatment of heart failure announced adding two industry veterans to its leadership team. Dale Sander has joined as Chief Financial Officer. Dr. Francis Plat will serve in an advisory capacity as Chief Strategy Officer. http://photos.prnewswire.com/prnvar/20131028/DC04442LOGO Mr. Sander has more than 20 years of...

2014-06-02 08:31:38

CAMBRIDGE, Mass., June 2, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has appointed Roger J. Pomerantz, M.D., F.A.C.P. as its President and Chief Executive Officer. Dr. Pomerantz will also remain as Chairman of the Board of Directors of Seres, where he has served since November of 2013. Dr. Pomerantz brings...

2014-05-29 23:01:30

James Matthew Gould joins RatnerPrestia as Counsel responsible for strategic patent portfolio management, patent due diligence, freedom-to-operate assessments, validity and infringement opinions; client counseling, patent prosecution, tech transfer and licensing. Gould joined after twenty years with Merck & Co./Schering-Plough as Legal Director. Valley Forge, PA (PRWEB) May 29, 2014 RatnerPrestia is pleased to announce that James Matthew Gould has joined their Valley Forge, PA office...

2014-05-20 08:33:00

First Chewable Tablet for Dogs Effective for 12 Weeks* Against Fleas and Ticks SUMMIT, N.J., May 20, 2014 /PRNewswire/ -- Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced the U.S. Food and Drug Administration's approval of BRAVECTO(TM) (fluralaner) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). BRAVECTO is the first and only treatment that has been shown to quickly and effectively kill fleas and multiple tick...

2014-05-19 16:24:18

Appoints Nicholas A. Saccomano, Ph.D. as Chief Scientific Officer and Robert E. Winkler, M.D. as Vice President of Clinical Development BOULDER, Colo., May 19, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, today announced the appointments of Nicholas A. Saccomano, Ph.D., as Chief Scientific Officer and Robert E....

2014-05-13 08:33:45

BUFFALO, N.Y., May 13, 2014 /PRNewswire/ -- Kinex Pharmaceuticals announces the addition of two key executives to its clinical leadership team reporting to Chief Medical Officer, Dr. Rudolf Kwan. Douglas Kramer MD joins Kinex as Vice President of Clinical and Regulatory Affairs and Jane Devane has joined Kinex as Director of Clinical Operations. Dr. Kramer adds significant regulatory and clinical risk management experience and was previously a Medical Officer for the United...

2014-05-06 08:36:14

RICHMOND, Va., May 6, 2014 /PRNewswire/ -- Global Genomics Group (G3), a life sciences company investigating biological networks that lead to the development of disease to identify novel diagnostic biomarkers and therapeutic targets, today announced the appointment of Harry "Chip" Davis, Jr., Ph.D., as chief drug development officer. Dr. Davis will be leading the drug discovery group together with Szilard Voros, M.D., co-founder and CEO of G3. "We are pleased that such an...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related